Presentation
13 March 2024 Verteporfin photodynamic therapy enhances therapeutic delivery of a tumor suppressor microRNA to pancreatic cancer cells
Author Affiliations +
Abstract
Countless trials of chemotherapy and/or targeted agent combinations have failed to produce substantial gains in survival for patients with pancreatic ductal adenocarcinoma. Recent studies have demonstrated exciting potential of RNA medicine approaches to therapeutically target microRNAs (miRNA, small non-coding RNAs) either by inhibiting tumor promoting miRNAs (onco-miRs) or enriching tumor suppressor miRNAs. Here we use co-culture and murine models to show that photodynamic therapy (PDT) using verteporfin both improves delivery and synergizes mechanistically with tumor suppressive effects of miR-146a-5p. These results indicate promise RNA medicine strategies for PDAC and could have broader applicability in therapeutic delivery of RNA medicine to solid tumors.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Vida Karimnia, Shakir Khan, Frank Slack, and Jonathan P. Celli "Verteporfin photodynamic therapy enhances therapeutic delivery of a tumor suppressor microRNA to pancreatic cancer cells", Proc. SPIE PC12823, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXXII, PC128230G (13 March 2024); https://doi.org/10.1117/12.3004781
Advertisement
Advertisement
KEYWORDS
Photodynamic therapy

Tumors

Medicine

Pancreatic cancer

3D modeling

Nanoparticles

3D acquisition

Back to Top